Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$13M 6.3%
Total revenue, Q1 '25 ().

Did IM Cannabis Beat Earnings?

IM Cannabis (IMCC) reported Q1 '25 revenue of $13M, up 3.6% year-over-year, with reported EPS of $0.06.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — IM Cannabis’s job postings, web traffic, and employee business outlook. See the full IMCC stock analysis or the earnings calendar for upcoming reports.

IM Cannabis Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue14M13M13M13M14M11M8.7M—
Gross margin22.7%20.1%27.6%27.0%19.7%0.5%16.3%—
Operating margin6.9%-147.6%1.3%-2.8%-30.0%-25.1%-19.3%—
Net income-920,000-1M280,000-310,000-3.7M-5.5M-2.5M—
Net margin-6.6%-7.6%2.2%-2.4%-26.4%-48.7%-28.4%—
EPS——$0.06—————

IM Cannabis Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, IM Cannabis’s quarterly revenue moved from $14M to $0.

When Is IM Cannabis’s Next Earnings Date?

IM Cannabis reports earnings on a quarterly schedule. Its most recent report covered Q1 '25. For the confirmed upcoming date — and every other company reporting soon — see the IMCC earnings calendar.

Frequently Asked Questions: IM Cannabis Earnings

IM Cannabis's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

IM Cannabis reported Q1 '25 EPS of $0.06 on revenue of $13M (+3.6% YoY). IM Cannabis reported EPS of $0.06.

IM Cannabis reported Q1 '25 revenue of $13M, up 3.6% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the IMCC AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.